Influenza Vaccines, IFPMA IVS, Geneva, Switzerland.
Int Nurs Rev. 2012 Jun;59(2):161-7. doi: 10.1111/j.1466-7657.2011.00961.x. Epub 2011 Dec 2.
Many health authorities recommend routine influenza vaccination for healthcare workers (HCWs), and during the 2009 A (H1N1) pandemic, the World Health Organization (WHO) recommended immunization of all HCWs worldwide. As this remains an important area of policy debate, this paper examines the case for vaccination, the role of local guidelines, barriers to immunization and initiatives to increase uptake.
Seasonal influenza is a major threat to public health, causing up to 1 million deaths annually. Extensive evidence supports the vaccination of priority groups, including HCWs. Immunization protects HCWs themselves, and their vulnerable patients from nosocomial influenza infections. In addition, influenza can disrupt health services and impact healthcare organizations financially. Immunization can reduce staff absences, offer cost savings and provide economic benefits.
This paper reviews official immunization recommendations and HCW vaccination studies, including a recent International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) survey of 26 countries from each region of the world.
HCW immunization is widely recommended and supported by the WHO. In the IFPMA study, 88% of countries recommended HCW vaccination, and 61% supported this financially (with no correlation to country development status). Overall, coverage can be improved, and research shows that uptake may be impacted by lack of conveniently available vaccines and misconceptions regarding vaccine safety/efficacy and influenza risk.
Many countries recommend HCW vaccination against influenza. In recent years, there has been an increased uptake rate among HCWs in some countries, but not in others. Several initiatives can increase coverage, including education, easy access to free vaccines and the use of formal declination forms. The case for HCW vaccination is clear, and in an effort to further accelerate uptake as a patient safety measure, an increasing number of healthcare organizations, particularly in the USA, are implementing mandatory immunization policies, similar to other obligatory hygiene measures. However, it would be desirable if similar high vaccination uptake rates could be achieved through voluntary procedures.
许多卫生当局建议医护人员(HCWs)常规接种流感疫苗,并且在 2009 年 A(H1N1)大流行期间,世界卫生组织(WHO)建议全球所有 HCWs 进行免疫接种。由于这仍然是政策辩论的重要领域,本文研究了接种疫苗的理由、地方指南的作用、免疫接种障碍以及提高接种率的举措。
季节性流感是对公共卫生的重大威胁,每年导致多达 100 万人死亡。广泛的证据支持为包括 HCWs 在内的重点人群接种疫苗。免疫接种可保护 HCWs 及其脆弱的患者免受医院内流感感染。此外,流感可扰乱卫生服务并对医疗机构造成经济影响。免疫接种可减少员工缺勤,节省成本并带来经济效益。
本文综述了官方免疫接种建议和 HCW 疫苗接种研究,包括国际制药商和协会联合会(IFPMA)最近对来自世界各地区的 26 个国家的调查。
HCW 免疫接种得到了广泛的推荐和世界卫生组织的支持。在 IFPMA 研究中,88%的国家建议 HCW 接种疫苗,61%的国家在资金上支持(与国家发展状况无关)。总体而言,接种率可以提高,并且研究表明,由于缺乏方便的疫苗和对疫苗安全性/有效性和流感风险的误解,接种率可能受到影响。
许多国家建议 HCW 接种流感疫苗。近年来,一些国家的 HCWs 接种率有所提高,但其他国家则没有。有几项举措可以提高覆盖率,包括教育、方便获得免费疫苗以及使用正式的拒绝表格。HCW 接种的理由很充分,为了进一步加速作为患者安全措施的接种率,越来越多的医疗机构,特别是在美国,正在实施强制性免疫政策,类似于其他强制性卫生措施。但是,如果通过自愿程序能够实现类似的高接种率,那将是理想的。